Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-07
2011-06-07
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S241000, C514S243000, C514S245000, C514S256000
Reexamination Certificate
active
07956072
ABSTRACT:
The amide compound of the formula (I) [each symbol is as defined in the description] has a promoting action on neuritogenesis of trigeminal nerve cells, and the compound is useful as a corneal neuritogenesis promoter, an agent for recovering corneal sensitivity by promotion of corneal neuritogenesis, and an agent for treating dry eye.
REFERENCES:
patent: 5958944 (1999-09-01), Arita et al.
patent: 6218410 (2001-04-01), Uehata et al.
patent: 6277855 (2001-08-01), Yerxa
patent: 6649625 (2003-11-01), Azuma et al.
patent: 6673812 (2004-01-01), Azuma et al.
patent: 7109208 (2006-09-01), Takayama et al.
patent: 7485654 (2009-02-01), Takayama et al.
patent: 2003/0125351 (2003-07-01), Azuma et al.
patent: 2004/0106646 (2004-06-01), Takayama et al.
patent: 2004/0162315 (2004-08-01), Hellberg et al.
patent: 2006/0234922 (2006-10-01), Takayama et al.
patent: 1 034 793 (2000-09-01), None
patent: 1 566 184 (2005-08-01), None
patent: 2004/039403 (2004-05-01), None
Office Action issued in CN 200580000389.9 (with English translation).
T. U. Linna et al., “Recovery of Corneal Nerve Morphology Following Laser in situ Keratomileusis”, Exp. Eye Res., vol. 66, pp. 755-763, 1998.
T. U. Linna et al., “Effect of Myopic LASIK on Corneal Sensitivity and Morphology of Subbasal Nerves”, Investigative Ophthalmology & Visual Science, vol. 41, No. 2, pp. 393-397, Feb. 2000.
R. T. Ang et al., “Dry eye after refractive surgery”, Current Opinion in Ophthalmology, vol. 12, pp. 318-322 2001.
P. H. Ozdinler et al., “Regulation of Neurotrophin-Induced Axonal Responses via Rho GTPases”, The Journal of Comparative Neurology, vol. 438, pp. 377-387, 2001.
M. Negishi et al., “Rho Family GTPases as Key Regulators for Neuronal Network Formation”, J. Biochem., vol. 132, No. 2, pp. 157-166, 2002.
J. Horwath-Winter et al.,“Early changes in corneal sensation, ocular surface integrity, and tear-film function after laser-assisted subepithelial keratectomy”, J. Cataract Refract Surg., vol. 30, pp. 2316-2321, Nov. 2004.
Y. Chan et al., “Specificity a Neuronotrophic Factor from Rabbit Corneal Epithelial Cultures”, Exp. Eye. Res., vol. 41, pp. 687-699, 1985.
M. C. Arbelaez, “Nidek MK 2000 Microkeratome Clinical Evaluation”, Journal of Refractive Surgery, vol. 18, pp. S357-S360, May/Jun. 2002.
Saini Jagjit S, Mittal Sangeet, Graded corneal sensitivity for screening of diabetic retinopathy, Indian J. Ophthalmology, 44(4), 219-223, 1996.
Azuma Mitsuyoshi
Inoue Jun
Nakamura Yoshikuni
Takayama Yoshiko
Hartley Michael G
Mitsubishi Tanabe Pharma Corporation
Samala Jagadishwar
Senju Pharmaceutical Co. Ltd.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Agent for repairing corneal sensitivity containing amide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for repairing corneal sensitivity containing amide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for repairing corneal sensitivity containing amide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666674